title: Novartis licenses gene therapy to avoid monopoly.
authors.forename: V
authors.initials: V
authors.lastname: Glaser
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000628:therapy; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D015774:Ganciclovir / Q000627:therapeutic use; D015316:Genetic Therapy / Q000331:legislation & jurisprudence*; D005909:Glioblastoma / Q000628:therapy; D006077:Government Agencies; D006801:Humans; D008004:Licensure; D018139:Simplexvirus / Q000201:enzymology / Q000235:genetics; D013937:Thymidine Kinase / Q000235:genetics; D014481:United States
chemical_list: D000998:Antiviral Agents; D013937:Thymidine Kinase; D015774:Ganciclovir